Molecular engineering of cytochrome P450 and myoglobin for selective oxygenations

被引:10
|
作者
Ueno, T
Ohki, T
Watanabe, Y [1 ]
机构
[1] Nagoya Univ, Grad Sch Sci, Res Ctr Mat Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan
[2] Nagoya Univ, Grad Sch Sci, Dept Chem, Chikusa Ku, Nagoya, Aichi 4648602, Japan
关键词
cytochrome P450; myoglobin; compound I; peroxygenation; monooxidation; enantioselectivity;
D O I
10.1142/S108842460400026X
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Aspects of protein engineering of cytochrome P450 (P450) and myoglobin (Mb) to construct selective oxygenation catalysts have been described. Heme enzymes are known as biocatalysts for various oxidations but the design of substrate specificity has still remained one of the significant challenges because of dynamic nature of enzyme-substrate interactions. In particular, P450s are the most interesting targets among the heme enzymes because they are able to catalyze many types of monooxygenations such as hydroxylation, epoxidation, and sulfoxidation with high selectivity. Thus, many researchers have made efforts to convert the selectivity for natural substrates into that for unnatural substrates by several protein engineering approaches. On the other hand, we have reported a rational design of Mb to convert its oxygen carrier function into that of peroxidase or peroxygenase. The Mb mutants prepared in our work afford oxo-ferryl porphyrin radical cation (compound I) as observable species in Mb for the first time. Furthermore, some of the mutants we have constructed are useful for enantioselective oxygenations by oxygen transfer from the Mb-compound I to substrates. Copyright (c) 2004 Society of Porphyrins & Phthalocyanines.
引用
收藏
页码:279 / 289
页数:11
相关论文
共 50 条
  • [21] Molecular imaging of cytochrome P450 activity in mice
    Roncoroni, Chiara
    Rizzi, Nicoletta
    Brunialti, Electra
    Cali, James J.
    Klaubert, Dieter H.
    Maggi, Adriana
    Ciana, Paolo
    PHARMACOLOGICAL RESEARCH, 2012, 65 (05) : 531 - 536
  • [22] Molecular evolution of Cytochrome P450 (CYP) genes
    Kawashima, Ayaka
    GENES & GENETIC SYSTEMS, 2013, 88 (06) : 368 - 368
  • [23] Molecular Modeling of Cytochrome P450 and Drug Metabolism
    Wang, Jing-Fang
    Chou, Kuo-Chen
    CURRENT DRUG METABOLISM, 2010, 11 (04) : 342 - 346
  • [24] Molecular and Structural Evolution of Cytochrome P450 Aromatase
    Di Nardo, Giovanna
    Zhang, Chao
    Marcelli, Anna Giulia
    Gilardi, Gianfranco
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (02) : 1 - 16
  • [25] Engineering cytochrome P450 biocatalysts for biotechnology, medicine and bioremediation
    Kumar, Santosh
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2010, 6 (02) : 115 - 131
  • [26] The Cytochrome P450 Engineering Database: integration of biochemical properties
    Sirim, Demet
    Wagner, Florian
    Lisitsa, Andrey
    Pleiss, Juergen
    BMC BIOCHEMISTRY, 2009, 10
  • [27] Human Cytochrome P450 Interactions with Redox Partner Cytochrome P450 Reductase
    Burris-Hiday, Sarah
    Chai, Mengqi
    Gross, Michael L.
    Scott, Emily
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2023, 385
  • [28] Membrane Anchor of Cytochrome P450 Reductase Suppresses the Uncoupling of Cytochrome P450
    Miyamoto, Masayoshi
    Yamashita, Taku
    Yasuhara, Yuki
    Hayasaki, Akinori
    Hosokawa, Yukari
    Tsujino, Hirofumi
    Uno, Tadayuki
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2015, 63 (04) : 286 - 294
  • [29] Molecular cloning and expression of cDNAs encoding tobacco novel cytochrome P450 AND NADPH-cytochrome P450 oxidoreductase
    Yamada, T
    Imaishi, H
    Ohkawa, H
    FASEB JOURNAL, 1997, 11 (09): : A812 - A812
  • [30] Selective Hydroxylation of Alkanes Catalyzed by Cytochrome P450 Enzymes
    Wang, Xiling
    Chen, Jie
    Ma, Nana
    Cong, Zhiqi
    ACTA CHIMICA SINICA, 2020, 78 (06) : 490 - 503